Josh Boling

Josh Boling has worked in the pharmaceutical industry since 2004, starting as a Lead/Compounder at Bayer. In 2010, they moved to Allergan as a Sr. Compounder, followed by Teva Pharmaceuticals in 2013 as a Specialist 1, TSA. In 2016, they became a Manufacturing Supervisor at Lonza, and then a Supervisor at Cambrex in 2018. Most recently, they are an Operations Manager at American Injectables.

Josh Boling attended the University of Phoenix from 2010 to 2014, where they obtained a Bachelor's degree in Business Management. In 2011, they also attended the Texas Fire Academy, where they earned a certificate in Fire Science/Fire-fighting.